239 related articles for article (PubMed ID: 32696697)
1. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
Schaller MS; Chen M; Colas RA; Sorrentino TA; Lazar AA; Grenon SM; Dalli J; Conte MS
J Am Heart Assoc; 2020 Aug; 9(15):e016113. PubMed ID: 32696697
[TBL] [Abstract][Full Text] [Related]
2. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
[TBL] [Abstract][Full Text] [Related]
3. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
Grenon SM; Owens CD; Nosova EV; Hughes-Fulford M; Alley HF; Chong K; Perez S; Yen PK; Boscardin J; Hellmann J; Spite M; Conte MS
J Am Heart Assoc; 2015 Aug; 4(8):e002034. PubMed ID: 26296857
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.
Schaller MS; Zahner GJ; Gasper WJ; Harris WS; Conte MS; Hills NK; Grenon SM
J Clin Lipidol; 2017; 11(5):1289-1295. PubMed ID: 28778393
[TBL] [Abstract][Full Text] [Related]
5. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
Ramirez JL; Gasper WJ; Khetani SA; Zahner GJ; Hills NK; Mitchell PT; Sansbury BE; Conte MS; Spite M; Grenon SM
J Surg Res; 2019 Jun; 238():164-174. PubMed ID: 30771686
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
[TBL] [Abstract][Full Text] [Related]
7. Enriched Marine Oil Supplement Increases Specific Plasma Specialized Pro-Resolving Mediators in Adults with Obesity.
Al-Shaer AE; Regan J; Buddenbaum N; Tharwani S; Drawdy C; Behee M; Sergin S; Fenton JI; Maddipati KR; Kane S; Butler E; Shaikh SR
J Nutr; 2022 Jul; 152(7):1783-1791. PubMed ID: 35349683
[TBL] [Abstract][Full Text] [Related]
8. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
9. Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators.
Sobrino A; Walker ME; Colas RA; Dalli J
PLoS One; 2020; 15(12):e0242543. PubMed ID: 33326419
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acids and peripheral artery disease.
Grenon SM; Hughes-Fulford M; Rapp J; Conte MS
Vasc Med; 2012 Feb; 17(1):51-63. PubMed ID: 22363018
[TBL] [Abstract][Full Text] [Related]
11. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
12. Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution.
Casulleras M; Flores-Costa R; Duran-Güell M; Zhang IW; López-Vicario C; Curto A; Fernández J; Arroyo V; Clària J
Hepatol Commun; 2022 Jun; 6(6):1443-1456. PubMed ID: 35178899
[TBL] [Abstract][Full Text] [Related]
13. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
Grenon SM; Conte MS; Nosova E; Alley H; Chong K; Harris WS; Vittinghoff E; Owens CD
J Vasc Surg; 2013 Nov; 58(5):1283-90. PubMed ID: 23830313
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific modulation of lipid mediator's formation in murine adipose tissue by omega-3 fatty acids.
Kuda O; Rombaldova M; Janovska P; Flachs P; Kopecky J
Biochem Biophys Res Commun; 2016 Jan; 469(3):731-6. PubMed ID: 26707880
[TBL] [Abstract][Full Text] [Related]
15. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans.
Mayer K; Meyer S; Reinholz-Muhly M; Maus U; Merfels M; Lohmeyer J; Grimminger F; Seeger W
J Immunol; 2003 Nov; 171(9):4837-43. PubMed ID: 14568963
[TBL] [Abstract][Full Text] [Related]
16. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.
Fiala M; Terrando N; Dalli J
J Alzheimers Dis; 2015; 48(2):293-301. PubMed ID: 26401996
[TBL] [Abstract][Full Text] [Related]
17. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain.
Callan N; Hanes D; Bradley R
J Transl Med; 2020 Oct; 18(1):401. PubMed ID: 33087142
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous infusion of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro.
McCann ME; Moore JN; Carrick JB; Barton MH
Shock; 2000 Aug; 14(2):222-8. PubMed ID: 10947170
[TBL] [Abstract][Full Text] [Related]
19. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
Grenon SM; Owens CD; Alley H; Chong K; Yen PK; Harris W; Hughes-Fulford M; Conte MS
Vasc Med; 2013 Oct; 18(5):263-74. PubMed ID: 24052491
[TBL] [Abstract][Full Text] [Related]
20. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
